Recent research has shown that miRNAs are involved in processes such as myocardial cell proliferation, differentiation, and metastasis, and promote the progression of DCM. Despite these insights, the ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Diabetic cardiomyopathy (DCM), an independent diabetes complication, is characterized by abnormalities in ...

The hearts of people with hypertrophic cardiomyopathy are thicker, and must beat more forcefully to pump blood out and into the body. This can lead to a variety of symptoms, which may sometimes ...

Hypertrophic cardiomyopathy (HCM) is an underdiagnosed genetic heart condition. Raising awareness through advocacy can help increase the rates of diagnosis and proper management. HCM is when the ...

The parents of an eight-year-old diabetic girl in Australia who died after they denied her insulin for almost a week have each been sentenced to 14 years in jail for manslaughter. Elizabeth Struhs ...

Type 2 diabetes can cause complications if not managed properly. These include nerve damage, kidney disease, and stroke. You can help prevent these by having regular checkups with your doctor and ...

New Tech for Managing Type 1 Diabetes Is Effective for Older Adults Mar. 11, 2025 — New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older ...

Diabetes symptoms can sometimes turn into an emergency quickly and suddenly. It is essential to know the signs of an emergency and what to do if one arises. In type 1 diabetes, the immune system ...

Diabetic cardiomyopathy (DCM), an independent diabetes complication, is characterized by abnormalities in myocardial structure, function, and metabolism, including diminished myocardial contractility, ...

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...